The Pharmaceutical Research and Manufacturers of America (PhRMA) today released new advertising as part of its “From Hope to Cures” campaign, highlighting the stories of rare blood and lung cancer survivors.
The newest video in the collection features Matt, who was diagnosed nearly seven years ago with advanced non-small cell lung cancer. When he was diagnosed, he was given a slim chance of living up to five years. However, today Matt continues to lead an active life due to recent advancements in targeted gene therapies and innovations in cancer medicines.
The latest print and digital ads feature Jamie, a vibrant woman diagnosed 15 years ago with chronic myelogenous leukemia (CML). Watching her son grow up was a primary focus for her, and she’s been able to continue to do that and so much more. Thanks to advancements in CML treatments, today she maintains her sense of humor and imparts an infectious joy on those who meet her.
Earlier this year, the first collection of digital and print ads was released featuring Rhys, a five-year-old living with type 1 diabetes and celiac disease. Unveiled alongside the advertising was a video, titled “We’re Fighting Back,” which features both Rhys and Jamie, as well as Jen, a researcher who wakes up every day working to find new treatments and cures for patients.
To view the multimedia release go to:
http://www.multivu.com/players/English/7738431-phrma-from-hope-to-cures/
Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test that can detect the presence of pancreatic cancer as part of a panel of eight common cancers (pancreas, ovary, liver, stomach, esophagus, colorectum, lung and breast) as reported in the online edition of Science today. The test utilizes combined assays for genetic alterations and protein biomarkers and has the capacity not only to identify the presence of relatively early cancer, but also to localize the organ of origin of these cancers.
“The potential this has for pancreatic cancer is unprecedented,” says Anne Marie Lennon, M.D., Ph.D., Associate Professor of Medicine, Director, Pancreatic Cyst Center of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center. “We know that in 80-85 percent of pancreatic cancer cases, it’s detected too late, leaving the patient with few options. Developing a blood screening test for pancreatic cancer has been an urgent goal, because catching the disease early will be the way we get to long-term survival.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213751-lustgarten-foundation-pancreatic-cancer-blood-test/
The American Dental Association (ADA) kicks off its 12th national Give Kids A Smile® program Friday, Feb. 7. Dental professionals from across the nation are mobilizing to provide free oral health services to children and adolescents from underserved families throughout this year. As of this date, approximately 350,000 are registered, with more expected to register throughout the year.
Give Kids A Smile has become the world's largest oral health charitable program and an ADA access-to-care endeavor designed to encourage parents, health professionals and policymakers to address the year-round need for oral health care for all children. Each year, thousands of the nation's dentists, dental team members and many volunteers from the community provide free oral health care services to children from low-income families across the country.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/60006-american-dental-association-give-kids-a-smile-program
DePuy Synthes Companies today announced the launch of Hit Play, an educational initiative that encourages those dealing with hip or knee pain to stop settling for a life on ‘pause’ and instead take action to get back to the activities and people they love most.
Osteoarthritis is one of the most common reasons for severe hip or knee pain, affecting nearly 27 million Americans today and will potentially affect up to 67 million people by 2030.1,2 In turn, demand for hip and knee replacements are expected to dramatically increase, yet many women see joint replacement as a “last resort” and often wait until the pain has become unbearable before turning to surgery. Through a series of compelling and relatable content, DePuy Synthes seeks to inspire the millions of people stuck on ‘pause’ due to hip or knee pain to explore joint replacement with a doctor, as a potential viable solution when they Hit Play.
To view the multimedia release go to:
http://www.multivu.com/players/English/79644241-lysol-madison-square-bgca-expose-germs/
Results from a new national survey released today indicate that our lifestyle exacerbates the challenge of trying to lose weight, making it more difficult than ever for adults to do so. Findings further suggest that adults who are trying to lose weight need a new approach that’s compatible with how we live today.
Specifically, most healthcare professionals and a majority of U.S. adults say losing weight is harder today than it was for previous generations because of the busy, modern lifestyle of Americans (77% of primary care physicians or PCPs, 81% of pharmacists, 62% U.S. adults). In fact, approximately seven in 10 healthcare professionals say it’s harder for Americans today to lose weight compared to just 10 years ago (69% of PCPs, 73% of pharmacists), and the vast majority believe Americans need to take a new approach to weight loss that fits with today’s modern lifestyle (89% of PCPs, 95% of pharmacists).
To view the multimedia release go to:
https://www.multivu.com/players/English/8215151-the-truth-about-weight-loss-national-survey/
To raise awareness about the importance of healthy, enhanced vision and its connection to enjoying the “sights” while traveling and in everyday life, Transitions® adaptive lenses™ and Food Network® host and celebrity chef Robert Irvine have teamed up to highlight ways to make the most of your travel and dining experiences, including wearing the right eyewear that allows you to see your best and enjoying flavorful eye healthy foods.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7095451-transitions-adaptive-lenses-wearer-robert-irvine-turns-dining-into-sightseeing/
Dornier MedTech® America, a global medical device company and the pioneer of Extracorporeal Shock Wave Lithotripsy (ESWL®), has received FDA clearance to market the Delta® III. This is the latest generation of the world’s best-selling and most clinically cited lithotripter, the Delta II.
To view the multimedia release go to:
https://www.multivu.com/players/English/8134451-dornier-medtech-delta-iii-kidney-stone-lithotripter/
The cosmetic industry has been pulling the wool over your eyes as their cosmetics continue to have ingredients that are harmful and even deadly to your health. But, they have no shame since they continue to add these ingredients to their cosmetics because they make the product smell better, flow nicer, cost less, dilute easy, easy to obtain, and fool you that they work.
Cigna (NYSE: CI) today unveiled its new TV Doctors of America campaign to encourage people to improve their health by going for their annual check-up, knowing their biometric numbers for blood pressure, cholesterol, blood sugar and body mass index (BMI), and taking control of their health. Supporting Cigna’s effort are actors Patrick Dempsey, Donald Faison, Neil Patrick Harris and Kate Walsh. All four actors starred as doctors on TV and are striking doctor poses, donning scrubs and using their celebrity influence to shine a spotlight on preventive care and the importance of going to a real doctor for an annual check-up that can help save lives.
To view the multimedia release go to:
https://www.multivu.com/players/English/8163851-cigna-americas-tv-doctors-go-know-take-control/
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7092251-fda-approve-s-exact-sciences-cologuard-screening-test-colorectal-cancer/
When the mid-afternoon rolls around, many of us wouldn’t mind curling up in bed and taking a nap. In fact, a recent study conducted by GfK’s KnowledgePanel® found that one-third of Americans say they feel drowsy, less productive and worn out several times a week, at an average of 2:58 pm.
This afternoon crash can be improved with the help of a healthy snack like almonds. Together, California Almonds and actress Anna Camp have partnered to ensure Americans can “Carpe PM” – or “seize the afternoon” -- and crunch their crash.
To view the multimedia release go to:
https://www.multivu.com/players/English/8118051-california-almonds-anna-camp-carpe-pm/
PetSafe® Brand, an industry leader in the development of innovative pet behavioral, containment and lifestyle product solutions, is encouraging dog owners to get outside with their pet this spring through its new outdoor campaign.
“Let’s Go Outside” promotes the importance of a fit lifestyle for pets, which is essential for maintaining good health and quality of life. Pet parents play a key role in making sure their dogs get regular physical activity.
To view the multimedia release go to:
http://www.multivu.com/players/English/7808351-petsafe-lets-go-outside-campaign/
